tiprankstipranks
Trending News
More News >

Microba Life Sciences Announces Quotation of New Securities on ASX

Story Highlights
Microba Life Sciences Announces Quotation of New Securities on ASX

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Microba Life Sciences Limited ( (AU:MAP) ).

Microba Life Sciences Limited has announced the quotation of 67,177,796 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code MAP. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the accessibility of its shares.

The most recent analyst rating on (AU:MAP) stock is a Buy with a A$0.33 price target. To see the full list of analyst forecasts on Microba Life Sciences Limited stock, see the AU:MAP Stock Forecast page.

More about Microba Life Sciences Limited

Microba Life Sciences Limited operates in the biotechnology industry, focusing on microbiome analysis and related health services. The company is known for its advanced microbiome testing and analysis products, which are utilized in both healthcare and research settings.

Average Trading Volume: 202,977

Technical Sentiment Signal: Sell

Current Market Cap: A$38.52M

For detailed information about MAP stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1